首页> 外文期刊>Therapeutic Drug Monitoring >Determination of 6-thioguanosine diphosphate and triphosphate and nucleoside diphosphate kinase activity in erythrocytes: novel targets for thiopurine therapy?
【24h】

Determination of 6-thioguanosine diphosphate and triphosphate and nucleoside diphosphate kinase activity in erythrocytes: novel targets for thiopurine therapy?

机译:测定红细胞中的6-硫代鸟苷二磷酸和三磷酸及核苷二磷酸激酶活性:硫嘌呤治疗的新靶点?

获取原文
获取原文并翻译 | 示例
           

摘要

6-Thioguanine nucleotides are the sum of 6-thioguanosine 5'-monophosphate (TGMP), -diphosphate (TGDP), and -triphosphate (TGTP) representing essential metabolites involved in drug action of thiopurines. Elevated levels of TGDP have been associated with poor response to azathioprine therapy in patients with inflammatory bowel disease. The conversion of TGDP to TGTP is supposed to be catalyzed by nucleoside diphosphate kinase (NDPK). The aim of this work was to investigate simultaneously individual 6-thioguanosine phosphate levels and NDPK activity in red blood cells (RBCs) of patients on azathioprine therapy. Ion-pair high-performance liquid chromatography methods with fluorescence and ultraviolet detection were applied to quantify individual levels of 6-thioguanosine 5'-phosphates and NDPK activity, respectively, in RBCs. Recombinantly expressed NDPK isoforms A and B were unequivocally identified to catalyze the formation of TGTP (30.6 +/- 3.88 nmol x min x mg for NDPK A versus 41.2 +/- 1.05 nmol x min x mg for NDPK B). Comprehensive analyses on the stability of TGMP, TGDP, and TGTP and the reproducibility of NDPK activity in RBCs were performed to provide a reliable sampling protocol for clinical practice. Of note, isolation of RBCs within 6 hours followed by immediate storage at -80 degrees C is crucial for prevention of degradation of 5'-phosphates. In a clinical study of 37 patients on azathioprine, TGTP was the predominant 6-thioguanosine phosphate in RBCs. In contrast, three patients showed TGTP/(TGDP + TGTP) ratios of 57.2%, 64.3%, and 66% corresponding to elevated TGDP levels. NDPK activity ranged from 4.1 to 11.3 nmol x min x mg hemoglobin. No correlation between NDPK activity and the 6-thioguanosine phosphate levels was found. The question whether interindividual variability of NDPK activity may explain differences in 6-thioguanosine 5'-phosphates levels has to be investigated in a prospective large-scale study.
机译:6-硫鸟嘌呤核苷酸是6-硫鸟嘌呤5'-单磷酸酯(TGMP),-二磷酸酯(TGDP)和-三磷酸酯(TGTP)的总和,代表参与硫嘌呤药物作用的基本代谢产物。在炎症性肠病患者中,TGDP水平升高与对硫唑嘌呤疗法的不良反应有关。 TGDP向TGTP的转化被认为是由核苷二磷酸激酶(NDPK)催化的。这项工作的目的是同时研究接受硫唑嘌呤治疗的患者的个体6-硫鸟嘌呤磷酸水平和红细胞(RBC)中的NDPK活性。应用具有荧光和紫外线检测功能的离子对高效液相色谱法分别对RBC中6-硫鸟嘌呤5'-磷酸的水平和NDPK活性进行了定量。明确鉴定了重组表达的NDPK同工型A和B,以催化TGTP的形成(NDPK A为30.6 +/- 3.88 nmol x min x mg,而NDPK B为41.2 +/- 1.05 nmol x min x mg)。对TGMP,TGDP和TGTP的稳定性以及RBC中NDPK活性的可再现性进行了综合分析,为临床实践提供了可靠的采样方案。值得注意的是,在6小时内分离RBC,然后立即在-80摄氏度下保存对于防止5'-磷酸盐降解至关重要。在对37名硫唑嘌呤患者的临床研究中,TGTP是RBC中主要的6-硫鸟嘌呤磷酸酯。相比之下,三名患者的TGTP /(TGDP + TGTP)比率分别为57.2%,64.3%和66%,与TGDP水平升高相对应。 NDPK活性范围为4.1至11.3nmol×min×mg血红蛋白。没有发现NDPK活性和6-硫鸟嘌呤磷酸水平之间的相关性。 NDPK活性的个体差异是否可以解释6-硫代鸟苷5'-磷酸酯水平的差异这一问题必须在前瞻性大规模研究中进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号